ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
 
Sponsors and Collaborators

Sidney Kimmel Comprehensive Cancer Center
National Cancer Institute (NCI)
 
Contact
Clinical Trials Office – Sidney Kimmel Comprehensive Cancer Center
410-955-8804
[email protected]
 
Principal Investigators
Judith E. Karp, MD
Sidney Kimmel Comprehensive Cancer Center
 
ClinicalTrials.gov Identifier
NCT00588991